MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Income Overview

Revenue
$9,325K
Net Income
-$62,045K
Net Profit Margin
-665.36%
EPS
-$0.93
Unit: Thousand (K) dollars
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
9,325
6,229
1,402
10,632
Research and development
49,501
39,673
41,695
37,696
Sales, general and administrative
25,253
19,974
21,146
16,027
Total operating expenses
74,754
59,647
62,841
53,723
(loss) income from operations
-65,429
-53,418
-61,439
-43,091
Interest income (expense), net
3,503
3,397
3,615
3,463
Other income
308
18
-110
3
Total other income (expense)
3,811
3,415
3,505
3,466
(loss) income before income taxes
-61,618
-50,003
-
-39,625
Provision for income taxes
0
0
-
-1,278
Net (loss) income
-61,618
-50,003
-57,934
-38,347
Unrealized (loss) gain on marketable securities
-427
-658
97
350
Total other comprehensive (loss) gain
-427
-658
97
350
Comprehensive (loss) income
-62,045
-50,661
-57,837
-37,997
Basic EPS
-0.93
-0.79
-0.932
-0.65
Diluted EPS
-0.93
-0.79
-0.956
-0.65
Basic Average Shares
66,017,895
63,063,507
62,048,530
58,611,677
Diluted Average Shares
66,017,895
63,063,507
60,512,604
58,611,677
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

STOK Income Statement Sankey DiagramSankey diagram visualizing STOK income statement for the periodComprehensive (loss) income-$62,045K (-166.48%↓ Y/Y)Net (loss) income-$61,618K (-162.39%↓ Y/Y)Total othercomprehensive (loss) gain-$427K (-313.50%↓ Y/Y)Interest income(expense), net$3,503K (-7.55%↓ Y/Y)Other income$308K (1000.00%↑ Y/Y)(loss) income beforeincome taxes-$61,618K (-162.39%↓ Y/Y)Unrealized (loss) gain onmarketable securities-$427K (-313.50%↓ Y/Y)Total other income(expense)$3,811K (-0.16%↓ Y/Y)(loss) income fromoperations-$65,429K (-139.67%↓ Y/Y)Revenue$9,325K (-32.51%↓ Y/Y)Total operatingexpenses$74,754K (81.81%↑ Y/Y)Research and development$49,501K (91.46%↑ Y/Y)Sales, general andadministrative$25,253K

Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics, Inc. (STOK)